Reply to “Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?”
Heart and Vessels · 19.08.2026
DOI: 10.1007/s00380-026-02744-6 ↗Kurz gefasst
Leserbrief in der Zeitschrift Heart and Vessels, online erschienen am 19.08.2026. Verfasst von Makoto Kishihara und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. Die Arbeit nennt 3 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
- Department of Cardiology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. yuichiro24@celery.ocn.ne.jp.
Zitieren
APA
Kishihara, M., Minami, Y., Hattori, H., Haruki, S., & Yamaguchi, J. (2026). Reply to “Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?”. Heart and Vessels. https://doi.org/10.1007/s00380-026-02744-6
Vancouver
Kishihara M, Minami Y, Hattori H, Haruki S, Yamaguchi J. Reply to “Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?”. Heart and Vessels. 2026. doi:10.1007/s00380-026-02744-6
BibTeX
@article{Kishihara2026,
author = {Kishihara, Makoto and Minami, Yuichiro and Hattori, Hidetoshi and Haruki, Shintaro and Yamaguchi, Junichi},
title = {Reply to “Acute heart failure and interleukin-6: Biomarker, bystander, or therapeutic target?”},
journal = {Heart and Vessels},
year = {2026},
doi = {10.1007/s00380-026-02744-6}
}
EUVIMED